Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy
OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm fol...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2011-10-01
|
Series: | International Brazilian Journal of Urology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007 |
id |
doaj-bdc4e8ac68304d6c8340b370eeb45559 |
---|---|
record_format |
Article |
spelling |
doaj-bdc4e8ac68304d6c8340b370eeb455592020-11-24T23:54:57ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192011-10-0137561161610.1590/S1677-55382011000500007Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomyB LojanapiwatM TanthanuchC PripathanontS RatchanonS SrinualnadT TaweemonkongsapS KanyokS LammongkolkulOBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1 % of treated and control group were stone-free, respectively. The increased stone size found in 7.7% and 54.5% of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007kidneycalculilithotripsycitratesurolithiasis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
B Lojanapiwat M Tanthanuch C Pripathanont S Ratchanon S Srinualnad T Taweemonkongsap S Kanyok S Lammongkolkul |
spellingShingle |
B Lojanapiwat M Tanthanuch C Pripathanont S Ratchanon S Srinualnad T Taweemonkongsap S Kanyok S Lammongkolkul Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy International Brazilian Journal of Urology kidney calculi lithotripsy citrates urolithiasis |
author_facet |
B Lojanapiwat M Tanthanuch C Pripathanont S Ratchanon S Srinualnad T Taweemonkongsap S Kanyok S Lammongkolkul |
author_sort |
B Lojanapiwat |
title |
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy |
title_short |
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy |
title_full |
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy |
title_fullStr |
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy |
title_full_unstemmed |
Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy |
title_sort |
alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy |
publisher |
Sociedade Brasileira de Urologia |
series |
International Brazilian Journal of Urology |
issn |
1677-5538 1677-6119 |
publishDate |
2011-10-01 |
description |
OBJECTIVE: To evaluate the preventive effects of alkaline citrate on stone recurrence as well as stone growth post-ESWL or PCNL in patients with calcium-containing stones. MATERIALS AND METHODS: A total of 76 patients with calcium calculi who were stone-free or had residual stones less than 4 mm following ESWL and PCNL were enrolled. All patients were independently randomized into two groups. The treated group (N = 39) was given 81 mEq per day of oral potassium-sodium citrate (27 mEq three times a day), and the untreated group (N = 37) serving as controls. Blood, twenty-four hour urine analysis, and plain KUB were measured and compared at the baseline and after 12 months. RESULTS: At baseline, hypocitraturia was found in 20 of 39 patients (46.05%) of Group I and 15 of 37 patients (40.5%) of Group II. At 12 months, hypocitraturia was found in 3 of 39 (7.69%) and 14 of 37 (37.83%) of Group I and Group II, respectively (p = 0.007). At the 12 month follow-up, of the stone-free group, 92.3% of the treated group and 57.7% of the control group were still stone free. Of the residual stone group, 30.8% and 9.1 % of treated and control group were stone-free, respectively. The increased stone size found in 7.7% and 54.5% of treated and control groups, respectively. CONCLUSION: Sodium-potassium citrate provides positive effects on stone-forming activities in calcium stone patients suffering from urolithiasis following treatment with ESWL and PCNL procedures at the 12-month follow-up. |
topic |
kidney calculi lithotripsy citrates urolithiasis |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000500007 |
work_keys_str_mv |
AT blojanapiwat alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT mtanthanuch alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT cpripathanont alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT sratchanon alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT ssrinualnad alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT ttaweemonkongsap alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT skanyok alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy AT slammongkolkul alkalinecitratereducesstonerecurrenceandregrowthaftershockwavelithotripsyandpercutaneousnephrolithotomy |
_version_ |
1725464188239740928 |